Guh, A. Y. et al. Trends in U.S. Burden of Clostridioides difficile infection and outcomes. N. Engl. J. Med. 382, 1320–1330 (2020).
Antibiotic Resistance Threats in the United States (Centers for Disease Control and Prevention, 2019); doi.org/10.15620/cdc:82532
Evans, C. T. & Safdar, N. Current trends in the epidemiology and outcomes of Clostridium difficile infection. Clin. Infect. Dis. 60, S66–S71 (2015).
Eyre, D. W. et al. Diverse sources of C. difficile infection identified on whole-genome sequencing. N. Engl. J. Med. 369, 1195–1205 (2013).
Walker, A. S. et al. Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing.PLoS Med. 9, e1001172 (2012).
Blixt, T. et al. Asymptomatic carriers contribute to nosocomial Clostridium difficile infection: a cohort study of 4508 patients. Gastroenterology 152, 1031–1041 (2017).
Galdys, A. L., Curry, S. R. & Harrison, L. H. Asymptomatic Clostridium difficile colonization as a reservoir for Clostridium difficile infection. Expert Rev. Anti Infect. Ther. 12, 967–980 (2014).
Furuya-Kanamori, L. et al. Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications. BMC Infect. Dis. 15, 516 (2015).
Sethi, A. K., Al-Nassir, W. N., Nerandzic, M. M., Bobulsky, G. S. & Donskey, C. J. Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection. Infect. Control Hosp. Epidemiol. 31, 21–27 (2010).
McDonald, L. C. & Diekema, D. J. Point-counterpoint: active surveillance for carriers of toxigenic Clostridium difficile should be performed to guide prevention efforts. J. Clin. Microbiol. 56, e00782-18 (2018).
Baron, S. W. et al. Screening of Clostridioides difficile carriers in an urban academic medical center: understanding implications of disease.Infect. Control Hosp. Epidemiol. 41, 149–153 (2020).
McDonald, L. C. et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin. Infect. Dis. 66, 987–994 (2018).
Didelot, X. et al. Microevolutionary analysis of Clostridium difficile genomes to investigate transmission. Genome Biol. 13, R118 (2012).
Surveillance for C. difficile, MRSA, and Other Drug-resistant Infections (Centers for Disease Control and Prevention, 2018); www.cdc.gov/nhsn/acute-care-hospital/cdiff-mrsa/index.html
Magill, S. S. et al. Multistate point-prevalence survey of health care–associated infections. N. Engl. J. Med. 370, 1198–1208 (2014).
Ponnada, S. et al. Acquisition of Clostridium difficile colonization and infection after transfer from a Veterans Affairs hospital to an affiliated long-term care facility. Infect. Control Hosp. Epidemiol. 38, 1070–1076 (2017).
Curry, S. R. et al. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission. Clin. Infect. Dis. 57, 1094–1102 (2013).
Riggs, M. M. et al. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin. Infect. Dis. 45, 992–998 (2007).
Sheth, P. M. et al. Evidence of transmission of Clostridium difficile in asymptomatic patients following admission screening in a tertiary care hospital. PLoS ONE 14, e0207138 (2019).
Kong, L. Y. et al. Clostridium difficile: investigating transmission patterns between infected and colonized patients using whole genome sequencing. Clin. Infect. Dis. 68, 204–209 (2019).
Zacharioudakis, I. M., Zervou, F. N., Pliakos, E. E., Ziakas, P. D. & Mylonakis, E. Colonization with toxinogenic C. difficile upon hospital admission, and risk of infection: a systematic review and meta-analysis. Am. J. Gastroenterol. 110, 381–390 (2015).
Eyre, D. W. et al. Asymptomatic Clostridium difficile colonisation and onward transmission. PLoS ONE 8, e78445 (2013).
Truong, C. et al. Clostridium difficile rates in asymptomatic and symptomatic hospitalized patients using nucleic acid testing. Diagn. Microbiol. Infect. Dis. 87, 365–370 (2017).
Clabots, C. R., Johnson, S., Olson, M. M., Peterson, L. R. & Gerding, D. N. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J. Infect. Dis. 166, 561–567 (1992).
Worley, J. et al. Genomic determination of relative risks for Clostridioides difficile infection from asymptomatic carriage in intensive care unit patients.Clin. Infect. Dis. 73, e1727–e1736 (2021).
Brazier, J. S. et al. Screening for carriage and nosocomial acquisition of Clostridium difficile by culture: a study of 284 admissions of elderly patients to six general hospitals in Wales. J. Hosp. Infect. 43, 317–319 (1999).
Lanzas, C. & Dubberke, E. R. Effectiveness of screening hospital admissions to detect asymptomatic carriers of Clostridium difficile: a modeling evaluation. Infect. Control Hosp. Epidemiol. 35, 1043–1050 (2014).
Longtin, Y. et al. Effect of detecting and isolating Clostridium difficile carriers at hospital admission on the incidence of C. difficile infections: a quasi-experimental controlled study. JAMA Intern. Med. 176, 796–804 (2016).
Tickler, I. A. et al. Strain types and antimicrobial resistance patterns of Clostridium difficile isolates from the United States, 2011 to 2013. Antimicrob. Agents Chemother. 58, 4214–4218 (2014).
Keegan, J. et al. Toxigenic Clostridioides difficile colonization as a risk factor for development of C. difficile infection in solid-organ transplant patients. Infect. Control Hosp. Epidemiol. 42, 287–291 (2021).
Shim, J. K., Johnson, S., Samore, M. H., Bliss, D. Z. & Gerding, D. N. Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet 351, 633–636 (1998).
Goldenberg, J. Z. et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.Cochrane Database Syst. Rev. 12, CD006095 (2017).
Mullane, K. M. et al. A randomized, placebo-controlled trial of fidaxomicin for prophylaxis of Clostridium difficile-associated diarrhea in adults undergoing hematopoietic stem cell transplantation. Clin. Infect. Dis. 68, 196–203 (2019).
Baunwall, S. M. D. et al. Faecal microbiota transplantation for recurrent Clostridioides difficile infection: an updated systematic review and meta-analysis. EClinicalMedicine 29–30, 100642 (2020).
Tamma, P. D. et al. Association of a safety program for improving antibiotic use with antibiotic use and hospital-onset Clostridioides difficile infection rates among US hospitals. JAMA Netw. Open 4, e210235 (2021).
Baur, D. et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect. Dis. 17, 990–1001 (2017).
Caroff, D. A., Yokoe, D. S. & Klompas, M. Evolving insights into the epidemiology and control of Clostridium difficile in hospitals. Clin. Infect. Dis. 65, 1232–1238 (2017).
Crobach, M. J. T. et al. Understanding Clostridium difficile colonization. Clin. Microbiol. Rev. 31, e00021-17 (2018).
Behroozian, A. A. et al. Detection of mixed populations of Clostridium difficile from symptomatic patients using capillary-based polymerase chain reaction ribotyping. Infect. Control Hosp. Epidemiol. 34, 961–966 (2013).
Dayananda, P. & Wilcox, M. H. A review of mixed strain clostridium difficile colonization and infection. Front. Microbiol. 10, 692 (2019).
Sun, J., Mc Millen, T., Babady, N. E. & Kamboj, M. Role of coinfecting strains in recurrent Clostridium difficile infection. Infect. Control Hosp. Epidemiol. 37, 1481–1484 (2016).
Seekatz, A. M. et al. Presence of multiple Clostridium difficile strains at primary infection is associated with development of recurrent disease. Anaerobe 53, 74–81 (2018).
Gonzalez-Orta, M. et al. Are many patients diagnosed with healthcare-associated Clostridioides difficile infections colonized with the infecting strain on admission? Clin. Infect. Dis. 69, 1801–1804 (2019).
Lin, M. Y. et al. Impact of mandatory infectious disease specialist approval on hospital-onset Clostridioides difficile infection rates and testing appropriateness.Clin. Infect. Dis. 77, 346–350 (2023).
Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114–2120 (2014).
Hunt, M. et al. ARIBA: rapid antimicrobial resistance genotyping directly from sequencing reads. Microb. Genom. 3, e000131 (2017).
Bankevich, A. et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J. Comput. Biol. 19, 455–477 (2012).
Seemann, T. Prokka: rapid prokaryotic genome annotation. Bioinformatics 30, 2068–2069 (2014).
Crawford, R. D. & Snitkin, E. S. cognac: rapid generation of concatenated gene alignments for phylogenetic inference from large, bacterial whole genome sequencing datasets. BMC Bioinformatics 22, 70 (2021).
Elliott, B., Androga, G. O., Knight, D. R. & Riley, T. V. Clostridium difficile infection: evolution, phylogeny and molecular epidemiology. Infect. Genet. Evol. 49, 1–11 (2017).
Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA–MEM. Preprint at doi.org/10.48550/arXiv.1303.3997 (2013).
Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078–2079 (2009).
Koenigsknecht, M. J. et al. Dynamics and establishment of Clostridium difficile infection in the murine gastrointestinal tract. Infect. Immun. 83, 934–941 (2015).
Kozich, J. J., Westcott, S. L., Baxter, N. T., Highlander, S. K. & Schloss, P. D. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl. Environ. Microbiol. 79, 5112–5120 (2013).
Schloss, P. D. et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 75, 7537–7541 (2009).
Schloss, P. D. A high-throughput DNA sequence aligner for microbial ecology studies. PLoS ONE 4, e8230 (2009).
Westcott, S. L. & Schloss, P. D. OptiClust, an improved method for assigning amplicon-based sequence data to operational taxonomic units. mSphere 2, e00073-17 (2017).
Baggs, J. et al. Risk of subsequent sepsis within 90 days after a hospital stay by type of antibiotic exposure. Clin. Infect. Dis. 66, 1004–1012 (2018).
Read more here: Source link
